Showing 20 of 24 recruiting trials for “toxic-dermatosis”
Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM)
👨⚕️ Michael Bubb, MD, Malcom Randall North Florida/South Georgia VA Medical Center📍 2 sites📅 Started Jan 2026View details ↗
RCT of Tocilizumab for Anti-MDA5+DM
RecruitingNCT07345949 ↗
Panniculitis in Dermatomyositis
Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis
Nebulized MSC-Exos for Anti-MDA5+ RP-ILD: Safety and Efficacy Trial
Intralesional Injection of STS in Treatment of Calcinosis
A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
Clinical Study of CD19 Targeted Universal Chimeric Antigen Receptor T Lymphocytes (UCAR-T) for the Treatment of Refractory Juvenile Dermatomyositis (RJDM)
Study of KYV-101 Anti-CD19 CAR T Therapy in Adult Dermatomyositis
Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis
👨⚕️ Meiping Lu, M.D, Children's Hospital, Zhejiang University School of Medicine📍 1 site📅 Started Jul 2024View details ↗
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
3T Therapy in the Treatment of MDA5-positive Dermatomyositis
🏥 Second Affiliated Hospital, School of Medicine, Zhejiang University📍 1 site📅 Started Mar 2024View details ↗
RecruitingNCT06203249 ↗
Microecology and Immunity in Patients With Anti-MDA5 Antibody Positive Dermatomyositis and Interstitial Lung Disease
Photoacoustic/Ultrasound Imaging in Patients of Dermatomyositis With Calcinosis Cutis: Characteristic Findings and Treatment Response Evaluation
RecruitingNCT06004817 ↗
Evaluation of Severity in Juvenile and Adult-onset Dermatomyositis
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
Interleukin-2 on Active Dermatomyositis
Baricitinib in Patients With Relapsing or naïve Dermatomyositis
👨⚕️ YVES ALLENBACH, MD, PhD, Assistance Publique Hopitaux de Paris📍 1 site📅 Started Aug 2022View details ↗
RecruitingNCT07265999 ↗
Severity Factors of Dermatomyositis in the Caribbean Population - DM-ANTILLES
Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study
Page 1 of 2Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →